Latest News and Press Releases

INBS wins major London transport contract, expanding use of its fingerprint drug testing solution ahead of planned U.S. market entry in 2025.

Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Drug Abuse Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...

Boston, July 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Global Pharmaceutical Drugs Industry: Competitive Landscape 2023" is projected to reach $2.2 trillion by...

Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "Drugs of Abuse (DoA) Testing Market Opportunities and Strategies to 2034" has been added to ResearchAndMarkets.com's offering. The drugs of abuse...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening...

Psychemedics’ 2025 Insights Report reveals rising synthetic drug threats, industry risk trends, and why hair testing remains the gold standard.

Boston, May 22, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “High-Throughput Screening: Technologies and Global Markets” is expected to grow from $23.8 billion in 2024...

Psychemedics named “Most Innovative Drug Testing Company of the Year” for advancing hair testing and launching Enhanced Quartile Reporting.

Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets Latin American drug screening market...